Showing results (241-250 of 1,825) with videos related to

Sort By:
Pageof 183
Oncology Reports|April 8, 2004
High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective studyRonnie Tung-Ping Poon, Cecilia Lau, Wan-Ching Yu, et al.
Cancers|August 14, 2025
HOXA5 as a Dual Modulator of Tumor Biology in Endometrial CancerYi-Kai Fu, Ching-Yu Shih, Chiao-Yin Cheng, et al.
Thorax|June 26, 2016
The short-term association between asthma hospitalisations, ambient temperature, other meteorological factors and air pollutants in Hong Kong: a time-series studyHolly Ching-Yu Lam, Albert Martin Li, Emily Ying-Yang Chan, et al.
BMC Bioinformatics|June 29, 2021
Transcript annotation tool (TransAT): an R package for retrieving annotations for transcript-specific genetic variantsChing-Yu Shih, Amrita Chattopadhyay, Chien-Hui Wu, et al.
Biotechnology Letters|March 25, 2014
Maintenance of human adipose derived stem cell (hASC) differentiation capabilities using a 3D cultureChing-Yu Lin, Chi-Hui Huang, Yuan-Kun Wu, et al.
Journal of Trauma & Dissociation : the Official Journal of the International Society for the Study of Dissociation (ISSD)|April 5, 2019
Adverse childhood experiences and dissociation among Hong Kong mental health service usersHong Wang Fung, Colin A Ross, Calvin Kai-Ching Yu, et al.
Nursing & Health Sciences|May 20, 2014
Survey of trend and factors in perinatal maternal fatigueChing-Yu Cheng, Yu-Hua Chou, Panchalli Wang, et al.
Japanese Journal of Clinical Oncology|July 3, 2013
Comparison of proxy ratings of main family caregivers and physicians on the quality of dying of terminally ill cancer patientsShao-Yi Cheng, Sydney Dy, Sin-Bao Huang, et al.
Clinical Kidney Journal|March 18, 2016
Does lower urine-specific gravity predict decline in renal function and hypernatremia in older adults exposed to psychotropic medications? An exploratory analysisSahar Sajadi, Ching Yu, Jean-Daniel Sylvestre, et al.
Journal of Managed Care & Specialty Pharmacy|June 23, 2022
Patient out-of-pocket and payer costs for pegfilgrastim originator vs biosimilars as primary prophylaxis of febrile neutropenia in the first cycle among a commercially insured populationChing-Yu Wang, Haesuk Park, Coy D Heldermon, et al.
Pageof 183